AP823A - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. - Google Patents

Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. Download PDF

Info

Publication number
AP823A
AP823A APAP/P/1998/001351A AP9801351A AP823A AP 823 A AP823 A AP 823A AP 9801351 A AP9801351 A AP 9801351A AP 823 A AP823 A AP 823A
Authority
AP
ARIPO
Prior art keywords
formula
alkyl
compound
compounds
groups include
Prior art date
Application number
APAP/P/1998/001351A
Other languages
English (en)
Other versions
AP9801351A0 (en
Inventor
Michael Dennis Dowle
Harry Finch
Lee Andrew Harrison
Graham George Adam Inglis
Martin Redpath Johnson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606508.1A external-priority patent/GB9606508D0/en
Priority claimed from GBGB9623001.6A external-priority patent/GB9623001D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AP9801351A0 publication Critical patent/AP9801351A0/xx
Application granted granted Critical
Publication of AP823A publication Critical patent/AP823A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
APAP/P/1998/001351A 1996-03-28 1997-03-26 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase. AP823A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606508.1A GB9606508D0 (en) 1996-03-28 1996-03-28 Chemical componds
GBGB9623001.6A GB9623001D0 (en) 1996-11-05 1996-11-05 Chemical compounds
PCT/EP1997/001530 WO1997036903A1 (en) 1996-03-28 1997-03-26 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (2)

Publication Number Publication Date
AP9801351A0 AP9801351A0 (en) 1998-09-30
AP823A true AP823A (en) 2000-04-25

Family

ID=26309008

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001351A AP823A (en) 1996-03-28 1997-03-26 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.

Country Status (30)

Country Link
US (3) US5994344A (hu)
EP (1) EP0891362B1 (hu)
JP (1) JP4118337B2 (hu)
KR (1) KR20000005039A (hu)
CN (1) CN1067075C (hu)
AP (1) AP823A (hu)
AR (1) AR006401A1 (hu)
AT (1) ATE261969T1 (hu)
AU (1) AU726649B2 (hu)
BR (1) BR9708449A (hu)
CA (1) CA2250209A1 (hu)
CO (1) CO4790152A1 (hu)
CZ (1) CZ309798A3 (hu)
DE (1) DE69728139T2 (hu)
DK (1) DK0891362T3 (hu)
EA (1) EA001437B1 (hu)
EE (1) EE9800335A (hu)
ES (1) ES2217404T3 (hu)
HU (1) HUP9900567A3 (hu)
IL (1) IL125859A0 (hu)
IS (1) IS4837A (hu)
NO (1) NO984470L (hu)
NZ (1) NZ331490A (hu)
PE (1) PE55298A1 (hu)
PL (1) PL329153A1 (hu)
PT (1) PT891362E (hu)
SK (1) SK132498A3 (hu)
TR (1) TR199801935T2 (hu)
WO (1) WO1997036903A1 (hu)
YU (1) YU41198A (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719189D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
GB9719172D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9719187D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9821199D0 (en) * 1998-09-30 1998-11-25 Glaxo Group Ltd Chemical compounds
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
AU2003216707A1 (en) * 2003-03-10 2004-09-30 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
TW201018661A (en) 2003-03-14 2010-05-16 Ono Pharmaceutical Co Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
US7692037B2 (en) * 2004-09-02 2010-04-06 Eastman Chemical Company Optimized liquid-phase oxidation
ES2457041T3 (es) 2004-09-13 2014-04-24 Ono Pharmaceutical Co., Ltd. Derivados de N-4-piperidilurea y medicamentos que los contienen como principio activo
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
JPWO2007105637A1 (ja) 2006-03-10 2009-07-30 小野薬品工業株式会社 含窒素複素環誘導体およびそれらを有効成分とする薬剤
CN101702904A (zh) * 2007-04-23 2010-05-05 西佳技术公司 用于治疗和预防正痘病毒感染和相关疾病的化合物、组合物和方法
JP5544296B2 (ja) 2007-11-16 2014-07-09 ライジェル ファーマシューティカルズ, インコーポレイテッド 代謝障害のためのカルボキサミド、スルホンアミド、およびアミン化合物
ES2553340T3 (es) 2007-12-12 2015-12-07 Rigel Pharmaceuticals, Inc. Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
JP5658138B2 (ja) 2008-04-23 2015-01-21 ライジェル ファーマシューティカルズ, インコーポレイテッド 代謝障害の処置のためのカルボキサミド化合物
NZ709153A (en) * 2012-12-18 2019-01-25 Chiesi Farm Spa Pyrimidinone derivatives having human neutrophil elastase inhibitory activity
EP4031138A1 (en) 2019-09-17 2022-07-27 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
MX2022012942A (es) 2020-04-16 2023-01-11 Mereo Biopharma 4 Ltd Metodos que involucran el inhibidor de la elastasa de neutrofilo alvelestat para el tratamiento de enfermedades respiratorias mediadas por deficiencia de alfa-1 antitripsina.
IL312002A (en) 2021-10-20 2024-06-01 Mereo Biopharma 4 Ltd Neutrophil elastase inhibitors for use in the treatment of fibrosis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024519A1 (en) * 1992-06-04 1993-12-09 Zeneca Limited Lactam dipeptides having hle inhibiting activity
WO1995021855A1 (en) * 1994-02-11 1995-08-17 Zeneca Limited Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932650A (en) * 1957-11-19 1960-04-12 Arthur C Cope 2-6-diazabicyclo (3. 3. 0) octanes
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
US5610296A (en) * 1994-12-05 1997-03-11 G. D. Searle & Co. Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024519A1 (en) * 1992-06-04 1993-12-09 Zeneca Limited Lactam dipeptides having hle inhibiting activity
WO1995021855A1 (en) * 1994-02-11 1995-08-17 Zeneca Limited Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase

Also Published As

Publication number Publication date
CA2250209A1 (en) 1997-10-09
US6057457A (en) 2000-05-02
BR9708449A (pt) 1999-08-03
NZ331490A (en) 2000-06-23
HUP9900567A3 (en) 2001-02-28
YU41198A (sh) 1999-09-27
DK0891362T3 (da) 2004-07-12
PT891362E (pt) 2004-08-31
US5994344A (en) 1999-11-30
EA199800773A1 (ru) 1999-06-24
NO984470D0 (no) 1998-09-25
JP4118337B2 (ja) 2008-07-16
PE55298A1 (es) 1998-09-19
CN1067075C (zh) 2001-06-13
AR006401A1 (es) 1999-08-25
IL125859A0 (en) 1999-04-11
PL329153A1 (en) 1999-03-15
HUP9900567A2 (hu) 1999-06-28
CZ309798A3 (cs) 1999-02-17
EE9800335A (et) 1999-04-15
JP2000507950A (ja) 2000-06-27
SK132498A3 (en) 1999-08-06
ATE261969T1 (de) 2004-04-15
AU2291797A (en) 1997-10-22
EP0891362B1 (en) 2004-03-17
US6215002B1 (en) 2001-04-10
DE69728139D1 (de) 2004-04-22
EP0891362A1 (en) 1999-01-20
TR199801935T2 (xx) 1999-03-22
CO4790152A1 (es) 1999-05-31
AP9801351A0 (en) 1998-09-30
CN1219935A (zh) 1999-06-16
DE69728139T2 (de) 2004-10-21
ES2217404T3 (es) 2004-11-01
NO984470L (no) 1998-11-25
WO1997036903A1 (en) 1997-10-09
IS4837A (is) 1998-08-28
AU726649B2 (en) 2000-11-16
KR20000005039A (ko) 2000-01-25
EA001437B1 (ru) 2001-02-26

Similar Documents

Publication Publication Date Title
AP823A (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
FI81085C (fi) Foerfarande foer framstaellning av nya, farmaceutiskt aktiva 1-sulfo-2-oxoazetidinderivat.
AU723658B2 (en) Reversible cysteine protease inhibitors
JP3192070B2 (ja) アスパラギン酸プロテアーゼ基質同配体の抗ウイルス性エーテル
US20070021354A1 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
US7429587B2 (en) Pyrrolidine derivatives as factor Xa inhibitors
CA2303176A1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
HRP20000136A2 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
US7179835B2 (en) 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
GB2206113A (en) 6-substituted penem esters as anti-inflammatory and anti-degenerative agents
US6177425B1 (en) Pyrrolopyrrolone derivatives
AU686780B2 (en) Composition for the treatment of lung disease
CA2486110A1 (en) Pharmaceutical combination
JPS6160816B2 (hu)
MXPA00011532A (en) Amidino and guanidino azetidinone tryptase inhibitors
CZ2000878A3 (cs) Pyrrolopyrrolonové deriváty